Clinical Trial
A Maintenance Protocol of Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors
Cancer Type
Siteman Kids- Pediatrics
Protocol Number
202107132
Principal Investigator
Learn more about this study at
clinicaltrials.gov
For more information contact us here:
Phone
800-600-3606Brief Summary
The primary objective of this study is to improve the 2-year progression-free survival in children with high-risk solid tumors who are administered a maintenance regimen with continuous sirolimus administered on a backbone of metronomic chemotherapy following the completion of standard therapy, as compared to high-risk solid tumor patients treated with observation alone following completion of standard therapy.
Protocol Interventions
Drug: Sirolimus, Drug: Cyclophosphamide, Drug: Etoposide, Drug: Celecoxib
Learn About Clinical Trials
Clinical trials are research studies that help us find new ways to prevent, diagnose, and treat cancer. If you are interested in participating in a clinical trial, our team will help you find a study that is right for you. Call us to speak with a Siteman care coordinator.